10.306 -0.034 (-0.33%) | 05-17 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 12.03 | 1-year : | 14.05 |
Resists | First : | 10.3 | Second : | 12.03 |
Pivot price | 10.28 | |||
Supports | First : | 10.26 | Second : | 10.23 |
MAs | MA(5) : | 10.3 | MA(20) : | 10.27 |
MA(100) : | 0 | MA(250) : | 0 | |
MACD | MACD : | 0 | Signal : | 0 |
%K %D | K(14,3) : | 100 | D(3) : | 100 |
RSI | RSI(14): 72.7 | |||
52-week | High : | 10.3 | Low : | 10.14 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ AFJK ] has closed below upper band by 8.0%. Bollinger Bands are 0% narrower than normal.
If tomorrow: | Open lower | Open higher |
High: | 10.32 - 10.37 | 10.37 - 10.41 |
Low: | 10.18 - 10.23 | 10.23 - 10.28 |
Close: | 10.22 - 10.31 | 10.31 - 10.38 |
Aimei Health Technology Co Ltd is a blank check company.
Thu, 18 Jan 2024
Aimei Health Technology Co., Ltd. Announces the Separate Trading of its Ordinary Shares and Rights Commencing ... - GlobeNewswire
Wed, 06 Dec 2023
Aimei Health Technology Co., Ltd Announces Closing of $69 Million Initial Public Offering - Yahoo Finance
Fri, 01 Dec 2023
Aimei Health Technology Co., Ltd Announces Pricing of $60 Million Initial Public Offering - GlobeNewswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Financial Services
|
|
Industry:
Shell Companies
|
|
Shares Out | 9 (M) |
Shares Float | 0 (M) |
Held by Insiders | 22.7 (%) |
Held by Institutions | 31.2 (%) |
Shares Short | 9 (K) |
Shares Short P.Month | 20 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |